Recent studies suggest an increase in the frequency of PSA testing in order to determine the rate PSA levels elevated prior to diagnosis of prostate cancer (“PSA velocity”) as a more realistic approach in prostate cancer risk stratification [5]. This evidence concerns the gene KLK3 and Familial prostate cancer.